PITRESSIN TANNATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pitressin Tannate, and what generic alternatives are available?
Pitressin Tannate is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in PITRESSIN TANNATE is vasopressin tannate. There are nine drug master file entries for this compound. Additional details are available on the vasopressin tannate profile page.
Summary for PITRESSIN TANNATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PITRESSIN TANNATE at DailyMed |
US Patents and Regulatory Information for PITRESSIN TANNATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | PITRESSIN TANNATE | vasopressin tannate | INJECTABLE;INJECTION | 003402-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |